The Oncology Institute, Inc.
General ticker "TOIIW" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $15.8M (TTM average)
The Oncology Institute, Inc. follows the US Stock Market performance with the rate: 3.4%.
Estimated limits based on current volatility of 12.7%: low 0.04$, high 0.05$
Factors to consider:
- Total employees count: 3 as of 2020
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.09$, 0.30$]
- 2026-12-31 to 2027-12-31 estimated range: [0.08$, 0.25$]
Short-term TOIIW quotes
Long-term TOIIW plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $393.41MM | $502.73MM |
| Operating Expenses | $453.53MM | $538.81MM |
| Operating Income | $-60.12MM | $-36.08MM |
| Non-Operating Income | $-4.54MM | $-24.65MM |
| Interest Expense | $7.50MM | $11.28MM |
| Income(Loss) | $-64.66MM | $-60.74MM |
| Taxes | $0.00MM | $-0.13MM |
| Profit(Loss)* | $-53.01MM | $-60.61MM |
| Stockholders Equity | $3.59MM | $-15.72MM |
| Assets | $172.72MM | $164.66MM |
| Operating Cash Flow | $-26.54MM | $-24.59MM |
| Capital expenditure | $3.79MM | $3.20MM |
| Investing Cash Flow | $46.21MM | $-3.07MM |
| Financing Cash Flow | $-3.49MM | $11.56MM |
| Earnings Per Share** | $-0.71 | $-0.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.